Health
Sequencing Study from Roswell Park Highlights Previously Unknown Myeloma Resistance Mechanisms – Newswise
— A group of researchers led by Maximillian Merz, MD, Assistant Professor of Oncology with the Myeloma team at Roswell Park Comprehensive Cancer Center, condu
- First single-cell analysis in a prospective trial for patients with myeloma
- Plasma-cell clones responsible for characteristic bone lesions, team shows
- Findings suggest new strategies for eradicating minimal residual disease
Newswise — BUFFALO, N.Y. — A group of researchers led by Maximillian Merz, MD, Assistant Professor of Oncology with the Myeloma team at Roswell Park Comprehensive Cancer Center, conducted the first prospective clinical trial investigating spatial heterogeneity in patients with either…
Continue Reading
-
General22 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News18 hours agoThe Laundry Lady secures $1M to fuel international expansion
-
Noosa News14 hours agoTruffle growers say rare delicacy is worth its $3,500 per kilo expense
-
General14 hours agoWA government is ‘spinning’ the results of community survey into Burswood Park racetrack and community hub, locals say